Q
QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

30,473 signal articles · 139 in last 24h · 154,280 total before filter · latest 1h ago
139last 24h
859last 7d
141● bullish (7d)
95● bearish (7d)
214publishers
AllMacro204Earnings105M&A125Regulatory21Product21Analyst19
Sentiment:bullishneutralbearishshow all (incl. clickbait)
Paramount's $110B Warner Bros. Discovery Merger Clears Legal Hurdle; Elizabeth Warren Says Letting Trump-Aligned Entity 'Dominate' News Is 'Disastrous'
Benzinga3d agoneutral
Paramount's $110B Warner Bros. Discovery Merger Clears Legal Hurdle; Elizabeth Warren Says Letting Trump-Aligned Entity 'Dominate' News Is 'Disastrous'

Paramount Skydance Corp.’s (NASDAQ:PSKY) $110 billion acquisition of Warner Bros. Discovery, Inc. (NASDAQ:WBD) has cleared a major legal hurdle after the company reached a settlement with a coalition of U.S. states and the Writers Guild of America. Paramount Warner Bros. Discovery Merger Clears Antitrust Fight The settlement on Monday allows the merger to move forward while requiring Paramount to accept several conditions aimed at addressing concerns over competition, jobs and media concentratio

Nasdaq Sees IPO Boom as AI, Tokenization and Fintech Fuel Growth
MarketBeat3d agoneutral
Nasdaq Sees IPO Boom as AI, Tokenization and Fintech Fuel Growth

Nasdaq (NASDAQ:NDAQ) CFO Sarah Youngwood said the company sees a constructive macroeconomic backdrop, citing investment in artificial intelligence and digital technologies, resilient consumers and corporate earnings that she said are supporting market valuations. Speaking at a fireside chat with an

Nvidia-Backed AI Drug Discovery Company Iambic Therapeutics Files for Nasdaq IPO, to Use Proceeds for Cancer Drug Development
Benzinga3d agoneutral
Nvidia-Backed AI Drug Discovery Company Iambic Therapeutics Files for Nasdaq IPO, to Use Proceeds for Cancer Drug Development

Iambic Therapeutics, Inc., an AI drug discovery company backed by Nvidia Corp. (NASDAQ:NVDA) and the Qatar Investment Authority, filed for an initial public offering, according to an S-1 filing with the SEC on Monday. Plans to List on Nasdaq, Under Ticker ‘IAM’ Iambic said it plans to use the IPO proceeds, along with its existing cash, to continue advancing its three cancer drug candidates through clinical development, with any remaining funds going toward general operating costs. It will go pub

CNN, MS NOW and Politico sue Trump, challenging White House ban
Reuters3d agoneutral
CNN, MS NOW and Politico sue Trump, challenging White House ban

WASHINGTON, Sept 21 (Reuters) - CNN, MS NOW and Politico sued President Donald Trump and other members of his administration on Monday for banning them from White House grounds, saying the action violated their rights to free speech and a free press under the US Constitution's First Amendment. The news outlets are seeking a temporary restraining order to block Trump's action in federal court in Washington, D.

New Era Energy surges 30% on 207 MW Vistra deal
Blockspace3d agobullishVIDEO
New Era Energy surges 30% on 207 MW Vistra deal

New Era Energy has signed a 207 MW power purchase agreement with Vistra for its planned Odessa, Texas, data center campus, advancing a project the company ultimately intends to scale…

5 Dividend ETFs to Buy Once and Never Sell for a 40-Year Retirement
24/7 Wall St.3d agoneutral
5 Dividend ETFs to Buy Once and Never Sell for a 40-Year Retirement

A retirement lasting 40 years will outlive most strategies built around fixed income alone, and five dividend ETFs cover every gap that leaves retirees vulnerable, from income growth against inflation to geographic exposure most US-focused portfolios quietly ignore.

'Years of Growth Left': Grimba
Bloomberg3d agoneutralVIDEO
'Years of Growth Left': Grimba

RBC Capital Markets Director of Global ETF Strategy Valerie Grimba joins Scarlet Fu and Eric Balchunas on "Bloomberg ETF IQ." They discuss the proliferation of new fund launches and how ETF issuers compete in an increasingly crowded space.

Test Your ETF Knowledge In Our IQ Test
Bloomberg3d agoneutralVIDEO
Test Your ETF Knowledge In Our IQ Test

Bloomberg's Scarlet Fu puts Eric Balchunas, Matt Kaufman of Calamos Investments, and Brittany Christensen at Tidal to the test on "Bloomberg ETF IQ" in this week's edition of "IQ Test."

Critics say California got too little in deal to let Paramount buy Warner Bros
Reuters3d agobullish
Critics say California got too little in deal to let Paramount buy Warner Bros

WASHINGTON, Sept 21 (Reuters) - Critics swiftly decried a California-driven settlement with Paramount Skydance that cleared the way for its $110 billion acquisition of Warner Bros Discovery, saying it will hurt competition in Hollywood, failed to protect jobs and lacks substantial ‌concessions from the media conglomerate. Opponents of the merger accused California Attorney General Rob Bonta and Governor Gavin Newsom of caving to wealthy interests, particularly ‌Paramount CEO David Ellison, afte

AMD Hits Milestone on Strong Day for Tech Stocks
The Wall Street Journal3d agoneutral
AMD Hits Milestone on Strong Day for Tech Stocks

Wall Street’s renewed AI optimism lifted data-center developers and suppliers, propelling Intel shares 12% higher and boosting Advanced Micro Devices by 10%. AMD notched a $1 trillion market capitalization for the first time, becoming the 14th U.

Trump Deal for Potash From Belarus Sends Fertilizer Stocks Down
The Wall Street Journal3d agoneutral
Trump Deal for Potash From Belarus Sends Fertilizer Stocks Down

In a move to lower fertilizer prices for American farmers, President Trump said the U.S. plans to buy potash from Belarus, undercutting higher-priced Canadian imports. Stocks of North American fertilizer companies fell Monday. Potash supplier Nutrien fell 3%.

What to know about Paramount's settlement and its impact on movies
Associated Press3d agoneutral
What to know about Paramount's settlement and its impact on movies

Movie studio Paramount on Monday agreed to settle an antitrust lawsuit filed by 12 states, the last big obstacle blocking the company's $81 billion acquisition of Warner Bros. Discovery in a deal that would transform the movie industry landscape. In the settlement, which still needs to be approved by a judge, Paramount agreed to terms including a five-year movie production plan and to invest $1.5 billion in domestic movies. State attorneys general say the settlement guarantees investment in domestic movie production and provides worker protection.